← Back to contracts

DoW Alzheimer’s Transforming Research Award

US Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526AZRPTRRA
Response due Sep 24, 2026 · 00:00 UTC

Summary

This is a federal grant opportunity issued by the Department of the Army through USAMRAA (U.S. Army Medical Research Acquisition Activity) under the Department of Defense (DoD). The award is focused on transforming research related to Alzheimer's disease, likely under the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). The opportunity is posted as a synopsis on Grants.gov and is open for submissions from May through September 2026. Full scope details are not provided in the synopsis text.

Risks & flags

  • Extremely limited scope information provided in synopsis — full program requirements and evaluation criteria are not disclosed in the available text
  • Opportunity number (HT942526AZRPTRRA) suggests a highly specific program line that may favor established DoD-funded research institutions

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Alzheimer’s Transforming Researc…
Due Sep 24
Onboard ↗